13 Feb 2023 Odimma partners with myNEO for the clinical development of its personalized DNA-based cancer immunotherapy Member news
09 Feb 2023 Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease Member news
09 Feb 2023 Biocartis announces the launch of the first assay developed with the new Idylla™ Flex Technology Member news
09 Feb 2023 Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01 Member news
09 Feb 2023 Launch of Biotope Ventures empowers young biotech startups in the biotope by VIB program Member news
08 Feb 2023 FINTEPLA®▼ (fenfluramine) oral solution approved in the EU for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) Member news
08 Feb 2023 Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure Member news
07 Feb 2023 Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture Member news
06 Feb 2023 Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
